ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home EGFR

More Than a Partnership: How Oncogene-Driven Patient Groups Are Mobilizing the Global Community to Drive Research

Upal Basu Roy
on: August 13, 2021In: Patient Advocacy & Survivorship
More Than a Partnership: How Oncogene-Driven Patient Groups Are Mobilizing the Global Community to Drive
            Research

It has been just over a year since we reported how oncogene-driven patient advocacy groups are disrupting the research paradigm in lung cancer.1 We have indeed come a long way […] Read more


Broad Molecular Testing in Lung Cancer: The Struggle to Translate Recommendations to Clinical Practice

on: June 24, 2020In: Evolving Standards of Care
Broad Molecular Testing in Lung Cancer: The Struggle to Translate Recommendations to Clinical Practice

By Kara Nyberg, PhD Posted: June 24, 2020 Over the past decade, lung cancer has emerged as a shining example of how precision medicine can dramatically improve patient outcomes. Up […] Read more

Stunning Progress Achieved in Lung Cancer Treatment Over the Last Decade

on: April 15, 2020In: Evolving Standards of Care
Stunning Progress Achieved in Lung Cancer Treatment Over the Last Decade

By Kara Nyberg, PhD Posted: April 16, 2020 After decades of failed clinical trials and persistently dismal lung cancer survival outcomes, the 2010s breathed new life into the beleaguered field […] Read more

Histologic Transformation From NSCLC to SCLC: A Mechanism of Resistance to Osimertinib and Other Agents Targeting EGFR Mutations

on: April 15, 2020In: Systemic, Targeted, & Immune Therapies
Histologic Transformation From NSCLC to SCLC: A Mechanism of Resistance to Osimertinib and Other Agents
            Targeting EGFR Mutations

By Denis Moro-Sibilot, MD, MSc Posted: April 16, 2020 Dr. Denis Moro-Sibilot EGFR tyrosine kinase inhibitors (TKIs) are the standard of care for mutated EGFR NSCLC. Today, one of the […] Read more

Letter to the Editor: Patient-Driven Research

on: December 10, 2019In: Patient Advocacy & Survivorship
Letter to the Editor: Patient-Driven Research

By Jill Feldman, EGFR Resisters Co-Founder Posted: December 11, 2019   Jill Feldman I was so glad to see the article by Dr. Amy Moore on PDX models in the October […] Read more

Adjuvant EGFR-TKI for Resected NSCLC: Who, When, and Where?

on: November 11, 2019In: Evolving Standards of Care
Adjuvant EGFR-TKI for Resected NSCLC: Who, When, and Where?

By Si-Yang Liu, MD, and Yi-Long Wu, MD Posted: November 12, 2019 Dr. Si-Yang Liu Dr. Yi-Long Wu In the twentieth century, adjuvant chemotherapy became the standard of care for […] Read more

SEARCH ILCN

Archives

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy